IOVA
Iovance Biotherapeutics Inc
$9.26
+7.67% (+$0.66)
Volume
21.03M
52W High
$9.41
52W Low
$1.76
Market Cap
$1.94B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.12
Whisper EPS
-$0.12
1.7% above consensus
Last Quarter
-$0.11
Current Streak
1 Beat
Avg Surprise (4Q)
+5.76%
Next Earnings Report
Reports in 50 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Aug 6, 2026
1-Day:
+2.09%
5-Day:
+4.51%
Q1 2026
May 7, 2026
1-Day:
+1.97%
5-Day:
+0.28%
Q1 2026
Mar 31, 2026
1-Day:
-1.71%
Q4 2025
Feb 24, 2026
1-Day:
+1.32%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $86.8M | +17.7% | 215.9% | -84.7% | -$71.9M |
| Q3'25 | $67.5M | +15.2% | 97.9% | -140.7% | -$91.3M |
| Q2'25 | $60.0M | +92.7% | 5.5% | -189.8% | -$111.7M |
| Q1'25 | $49.3M | +6,798.5% | -0.9% | -245.8% | -$116.2M |
| Q4'24 | $73.7M | +10,000.0% | 38.2% | -117.5% | -$78.6M |
| Q3'24 | $58.6M | +10,000.0% | 32.0% | -152.1% | -$83.5M |
| Q2'24 | $31.1M | +10,000.0% | -0.8% | -327.6% | -$97.1M |
| Q1'24 | $715,000 | -- | -915.5% | -10,000.0% | -$113.0M |
Company Information
Symbol
IOVA
Company
Iovance Biotherapeutics Inc
Market Cap
$1.94B
Next Earnings
Nov 5, 2026